Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Selinexor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Antengene Presents Late-Stage Selinexor Results at ASH 2024
    Antengene Presents Late-Stage Selinexor Results at ASH 2024

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/antengene-presents-results-from-two-late-stage-clinical-studies-of-selinexor-at-ash-2024-302324771.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share
    Karyopharm to Present Selinexor Data at ASH Annual Meeting
    Karyopharm to Present Selinexor Data at ASH Annual Meeting

    18 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/karyopharm-to-present-selinexor-data-at-the-66th-american-society-of-hematology-annual-meeting-and-exposition-302307992.html

    PR NEWSWIRE
    18 Nov 2024
    Share Share
    Orsini Now Provider for SAJAZIR Injection in Acute HAE Attacks
    Orsini Now Provider for SAJAZIR Injection in Acute HAE Attacks

    05 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orsini-now-a-specialty-pharmacy-provider-for-sajazir-icatibant-injection-to-treat-acute-hae-attacks-302295748.html

    PR NEWSWIRE
    05 Nov 2024
    Share Share
    Antengene's Xpovio® Approved For Third Indication In South Korea
    Antengene's Xpovio® Approved For Third Indication In South Korea

    17 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/antengene-announces-xpovio-selinexor-approved-for-its-third-indication-in-south-korea-bringing-fresh-hope-to-patients-with-mm-in-the-country-302279988.html

    PR NEWSWIRE
    17 Oct 2024
    Share Share
    Antengene To Commercialise XPOVIO In Thailand For Myeloma
    Antengene To Commercialise XPOVIO In Thailand For Myeloma

    23 Sep 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24928/antengene-receives-approval-to-commercialise-xpovio-in-thailand-for-multiple-myeloma-patients.html

    BIOSPECTRUM ASIA
    23 Sep 2024
    Share Share
    Karyopharm Reports Q2 2024 Results And Recent Progress
    Karyopharm Reports Q2 2024 Results And Recent Progress

    06 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/karyopharm-reports-second-quarter-2024-financial-results-and-highlights-recent-company-progress-302215439.html

    PR NEWSWIRE
    06 Aug 2024
    Share Share